Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts
Background Advanced glycation endproducts (AGEs) have been linked to cardiovascular disease (CVD) in cohorts with and without diabetes. Data are lacking on prospective associations of various α‐dicarbonyl‐derived AGEs and incident CVD in the general population. We tested the hypothesis that major pl...
Main Authors: | Julio A. Lamprea‐Montealegre, Alice M. Arnold, Robyn L. McCLelland, Kenneth J. Mukamal, Luc Djousse, Mary L. Biggs, David S. Siscovick, Russell P. Tracy, Paul J. Beisswenger, Bruce M. Psaty, Joachim H. Ix, Jorge R. Kizer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-08-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.024012 |
Similar Items
-
Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions
by: Suzan Wetzels, et al.
Published: (2019-04-01) -
Galectin‐3 and RAGE differentially control advanced glycation endproduct‐induced collagen damage in murine intervertebral disc organ culture
by: Zachary S. Gallate, et al.
Published: (2023-06-01) -
Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract
by: Timme van der Lugt, et al.
Published: (2020-09-01) -
Advanced glycation endproducts mediate chronic kidney injury with characteristic patterns in different stages
by: Xiaoxia Huang, et al.
Published: (2022-09-01) -
Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study
by: Isabella M. Atzeni, et al.
Published: (2020-11-01)